Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001750019-19-000046
Filing Date
2019-08-09
Accepted
2019-08-09 06:06:08
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr10q06302019.htm   iXBRL 10-Q 1961301
2 EXHIBIT 31.1 a311certificationofpri.htm EX-31.1 10328
3 EXHIBIT 31.2 a312certificationofpri.htm EX-31.2 10341
4 EXHIBIT 32.1 a321certifcationsofpri.htm EX-32.1 8451
10 LOGO tcr2logohires.jpg GRAPHIC 167882
  Complete submission text file 0001750019-19-000046.txt   7195547

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20190630.xsd EX-101.SCH 37664
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrr-20190630_cal.xml EX-101.CAL 64794
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrr-20190630_def.xml EX-101.DEF 195149
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20190630_lab.xml EX-101.LAB 558870
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20190630_pre.xml EX-101.PRE 321432
11 EXTRACTED XBRL INSTANCE DOCUMENT tcrr10q06302019_htm.xml XML 1041551
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 191011205
SIC: 2836 Biological Products, (No Diagnostic Substances)